Nobiletin alleviates alcoholic fatty liver disease by regulating lipid metabolism and oxidative stress via Ephx1 and Sult1a1

Key Points

• Nobiletin alleviates alcoholic fatty liver disease, positively impacting lipid metabolism and oxidative stress.
• Results show significant regulation of ephx1 and sult1a1 pathways, highlighting their role in treatment efficacy.
• Assessment of lipid profiles and oxidative markers was conducted through biochemical analysis and animal models.
• Findings support potential therapeutic applications for nobiletin in managing alcoholic fatty liver disease.